Leading the Charge

We’ve built a company poised to produce transformative pharmaceutical solutions by bringing together leaders steeped in all the functional areas needed to bring new drugs to life. With a deeply skilled management team directing our day-to-day wins, and a Board with a stellar track record, we’re acquiring, developing and commercializing drug candidates for diseases where there is a high unmet medical need.

Meet Our Best & Brightest

Bringing products to market for patients with high unmet medical need. Managing quality and regulatory compliance for a global biotech company. Overseeing clinical development for top-flight pharmaceutical companies. These are the back stories of just some of the bright minds you’ll find in the lab, meeting room and beyond at Dova Pharmaceuticals.

Jason Hoitt

Jason Hoitt Chief Commercial Officer

Mr. Hoitt joins Dova as our Chief Commercial Officer. Prior to Dova, Jason was the VP, Head of US Sales, at Insmed Inc. from May 2017 to December 2018. Prior to joining Insmed, Jason spent four years at Sarepta Therapeutics, where he held leadership roles in Medical Affairs and US Sales, and launched EXONDYS 51. Previously, Jason held senior positions in both marketing and sales at Vertex Pharmaceuticals, where he played an integral role in launching Incivek. From 2004 to 2010 Jason was at Gilead Sciences in a variety of roles of increasing responsibility, culminating in a lead role in the launch of Viread for HBV. Jason began his career as a bench researcher at Boston’s New England Medical Center, (Tufts Medical School), which led to biopharmaceutical roles at AstraZeneca and Schering Oncology-Biotech. Jason holds a B.A. from the College of the Holy Cross in Worcester, MA.